News and Opinion

Celebrate Springer Nature one millionth OA with author video

Dr. Xingcai Zhang is honored to be invited to celebrate the Springer Nature one millionth OA publication with the author video representing Nature Communications.

Published in Bioengineering & Biotechnology

Go to the profile of Xingcai Zhang
Xingcai Zhang
Celebrate Springer Nature one millionth OA with author video
Like
Go to the profile of Evelina Satkevic

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

Share with...

...or copy the link

This is a representation of how your post may appear on social media. The actual post will vary between social networks

The author video that Dr. Xingcai Zhang et al. took part in is now live on the Springer Nature YouTube channel and the landing page Springer Nature created to celebrate their one millionth OA article being published. Springer Nature will be using marketing channels over the next few weeks to direct viewers to it, and hoping to include it in some way in the 2021 OA annual report. Cheers Springer Nature and all for promoting open science!---Dr. Xingcai Zhang https://scholar.harvard.edu/xingcaizhang

Related reading:

https://scholar.google.com/citations?hl=en&user=2vDraMoAAAAJ&view_op=list_works&sortby=pubdate

https://orcid.org/0000-0001-7114-1095  

https://www.nature.com/articles/s41467-022-28744-4

https://www.nature.com/articles/s41565-021-01040-w

https://www.nature.com/articles/s41467-021-25075-8

https://www.nature.com/articles/s41467-021-24961-5

https://www.nature.com/articles/s41467-021-21436-5  

https://www.nature.com/articles/s41578-020-00247-y 

https://www.nature.com/articles/s41467-019-12462-5

Celebrate Springer Nature one millionth OA with author video

Celebrate Springer Nature one millionth OA with author video

Go to the profile of Xingcai Zhang
Xingcai Zhang (He/Him)

Dr. Zhang works on Nature materials including tea and microfluidics-powered living soft materials/Nature materials especially Nature-derived/inspired sustainable materials for advanced applications . Sustainable Nature-inspired/derived/mimetic materials, biomedicine, 2D/C/porous/polymer/bio-inspired materials. Dr. Xingcai Zhang, Harvard/MIT Research Fellow; Science Writer/Editorial (Advisory) Board Member for Springer Nature, AAAS, Materials Today, Royal Society of Chemistry, American Chemical Society; Wiley; with 5 STEM degrees and more than 150 high-impact journal publications in Nature Reviews Materials (featured cover paper, highly cited paper), Nature Nanotechnology(Highlighted news release paper), Nature Medicine, PNAS(Highlighted and highly cited paper), Nature Communications(Top 0.1% Highly cited papers, Editor`s choice papers), Science Advances(featured cover paper), etc.  https://scholar.google.com/citations?hl=en&user=2vDraMoAAAAJ&view_op=list_works&sortby=pubdate  +1-2253041387  

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Sign In Register

Follow the Topic

Biotechnology
Life Sciences > Biological Sciences > Biotechnology

Related Collections

With Collections, you can get published faster and increase your visibility.

Women's Health

A selection of recent articles that highlight issues relevant to the treatment of neurological and psychiatric disorders in women.

Publishing Model: Hybrid

Deadline: Ongoing

Explore this Collection

Tumor Microenvironment Crosstalk and Therapeutic Implications

With this cross-journal Collection, the editors at Nature Immunology, Nature Communications, Communications Medicine and Scientific Reports invite manuscripts that highlight cutting-edge research on TME crosstalk and its therapeutic implications. Topics of interest include immune modulation and checkpoint pathways, cancer-associated fibroblasts and stromal remodeling, angiogenesis and vascular normalization, metabolic reprogramming within the TME, and the role of microbiota in tumor-immune dynamics. We also welcome studies on novel therapeutic approaches that exploit TME vulnerabilities to advance cancer treatment.

Publishing Model: Hybrid

Deadline: Nov 02, 2026

Explore this Collection

Recommended Content

Cookies

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website. You can decide for yourself which categories you want to deny or allow. Please note that based on your settings not all functionalities of the site are available.

Further information can be found in our privacy policy.

Cookie Control

Customise your preferences for any tracking technology

The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.

See the full cookie policy See the full privacy policy
More information

These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.

More information

These trackers help us to deliver personalized marketing content and to operate, serve and track ads.

More information

These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.

More information

These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.

More information

These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.